Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Oral Submucous Fibrosis
NCT06332612Phase 2Completed
- Sponsor
- Ziauddin University
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin 1% gel in Oral submucous fibrosis (OSF), sponsored by Ziauddin University. Started Aug 2024; status: completed.
02
Drugs
metformin 1% gel
03
Conditions
Oral submucous fibrosis (OSF)
Beyond the preview
Go deeper on NCT06332612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06332612.